Literature DB >> 1908784

Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark.

K Lind1, M W Bentzon.   

Abstract

The study was based on a computerized card index of 9161 patients who had at least one positive blood specimen in the Mycoplasma pneumoniae complement fixation test. A total of 12,562 specimens from these patients had been sent to Statens Seruminstitut from hospitals and general practitioners during a 10.5-year period. The period encompassed a previously described endemic period in a 30-year study of the epidemiological pattern of M. pneumoniae infection in Denmark. The serological data presented support the hypothesis advanced here that a more than sixfold increase of children in day care might have contributed to a change in the epidemiological pattern. The correlation between age and level of specific antibodies, as well as persistence of seropositivity, were also investigated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908784      PMCID: PMC2272049          DOI: 10.1017/s0950268800048810

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  15 in total

1.  EATON PLEUROPNEUMONIA-LIKE ORGANISM (MYCOPLASMA PNEUMONIAE) COMPLEMENT-FIXING ANTIGEN: EXTRACTION WITH ORGANIC SOLVENTS.

Authors:  G E ENNY; J T GRAYSTON
Journal:  J Immunol       Date:  1965-07       Impact factor: 5.422

2.  Respiratory infections due to Mycoplasma pneumoniae in infants and children.

Authors:  G W Fernald; A M Collier; W A Clyde
Journal:  Pediatrics       Date:  1975-03       Impact factor: 7.124

3.  Changes in the epidemiological pattern of Mycoplasma pneumoniae infections in Denmark. A 30 years survey.

Authors:  K Lind; M W Bentzon
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

Review 4.  Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control.

Authors:  F W Denny; W A Clyde; W P Glezen
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

5.  Persistence of serum antibody following Mycoplasma pneumoniae infection.

Authors:  S Nakamura; I Ebisawa; O Kitamoto; T Sato
Journal:  Am Rev Respir Dis       Date:  1970-04

6.  Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections.

Authors:  G E Kenny; G G Kaiser; M K Cooney; H M Foy
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

7.  Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques.

Authors:  H Brunner; B Prescott; H Greenberg; W D James; R L Horswood; R M Chanock
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

8.  Relationship of pre-existing antibody to subsequent infection by Mycoplasma pneumoniae in adults.

Authors:  D P McCormick; R P Wenzel; L B Senterfit; W E Beam
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

9.  Isolation and characterization of Mycoplasma genitalium strains from the human respiratory tract.

Authors:  J B Baseman; S F Dallo; J G Tully; D L Rose
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

10.  Second attacks of pneumonia due to Mycoplasma pneumoniae.

Authors:  H M Foy; G E Kenny; R Sefi; H D Ochs; I D Allan
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

View more
  7 in total

1.  Outbreaks of Mycoplasma pneumoniae infections in Iceland 1987 to 1997 - a ten and a half years review.

Authors:  G S Hauksdottir; A Love; V Sigurdardottir; T Jonsson
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

2.  A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995.

Authors:  K Lind; M W Benzon; J S Jensen; W A Clyde
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

3.  Occurrence of serologically verified Mycoplasma pneumoniae infections in Poland in 1970-1995.

Authors:  W Rastawicki; S Kałuzewski; M Jagielski
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

4.  Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.

Authors:  S A Uldum; J S Jensen; J Søndergård-Andersen; K Lind
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

5.  Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods.

Authors:  M P Layani-Milon; I Gras; M Valette; J Luciani; J Stagnara; M Aymard; B Lina
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia.

Authors:  Le Wang; Zhishan Feng; Mengchuan Zhao; Shuo Yang; Xiaotong Yan; Weiwei Guo; Zhongren Shi; Guixia Li
Journal:  BMC Infect Dis       Date:  2017-07-25       Impact factor: 3.090

7.  Distributions of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003.

Authors:  Jinho Yu; Young Yoo; Do Kyun Kim; Hee Kang; Young Yull Koh
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.